Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation?

References

1. 1.↵
   A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes: Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971–83

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Aylward EH,
   2. Codori A,
   3. Rosenblatt A,
   4. et al

   . Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000; 15: 552–60

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Aylward EH,
   2. Rosenblatt A,
   3. Field K,
   4. et al

   . Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study. Brain Res Bull 2003; 62: 137–41

   CrossRefPubMed
4. 4.↵
   1. Aylward EH

   . Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Res Bull 2007; 72: 152–58. Epub 2006 Nov 2

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Aylward EH,
   2. Sparks BF,
   3. Field BA,
   4. et al

   . Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004; 63: 66–72

   CrossRefPubMed
6. 6.↵
   1. Le Bihan D,
   2. Turner R,
   3. Douek P,
   4. et al

   . Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159: 591–99

   PubMedWeb of Science
7. 7.↵
   1. Seppi K,
   2. Schocke MF,
   3. Mair KJ,
   4. et al

   . Diffusion-weighted imaging in Huntington's disease. Mov Disord 2006; 21: 1043–47

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Mascalchi M,
   2. Lolli F,
   3. Della NR,
   4. et al

   . Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004; 232: 867–73

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Rosas HD,
   2. Tuch DS,
   3. Hevelone ND,
   4. et al

   . Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006; 21: 1317–25

   CrossRefPubMedWeb of Science
10. 10.↵
    Guidelines for the molecular genetics predictive test in Huntington's disease: International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology 1994; 44: 1533–36

    CrossRef
11. 11.↵
    1. Langbehn DR,
    2. Brinkman RR,
    3. Falush D,
    4. et al

    . A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65: 267–77

    CrossRefPubMedWeb of Science
12. 12.↵
    Unified Huntington's Disease Rating Scale: reliability and consistency—Huntington Study Group. Mov Disord 1996; 11: 136–42

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Marder K,
    2. Zhao H,
    3. Myers RH,
    4. et al

    . Rate of functional decline in Huntington's disease: Huntington Study Group. Neurology 2000; 54: 452–58

    CrossRefPubMed
14. 14.↵
    1. Alemán-Gómez Y,
    2. Melie-García L,
    3. Valdés-Hernandez P

    . IBASPM: toolbox for automatic parcellation of brain structures. Presented at: 12th Annual Meeting of the Organization for Human Brain Mapping, Florence, Italy, June 11–15, 2006
15. 15.↵
    1. Tzourio-Mazoyer N,
    2. Landeau B,
    3. Papathanassiou D,
    4. et al

    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273–89

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Looi JC,
    2. Lindberg O,
    3. Liberg B,
    4. et al

    . Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res 2008; 163: 279–88

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Basser PJ,
    2. Mattiello J,
    3. LeBhian D

    . Estimation of the self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994; 103: 247–54

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kassubek J,
    2. Juengling FD,
    3. Kioschies T,
    4. et al

    . Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213–20

    Abstract/FREE Full Text
19. 19.↵
    1. Douaud G,
    2. Gaura V,
    3. Ribeiro MJ,
    4. et al

    . Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562–75

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Vonsattel JP,
    2. Myers RH,
    3. Stevens TJ,
    4. et al

    . Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559–77

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Taylor-Robinson SD,
    2. Weeks RA,
    3. Bryant DJ,
    4. et al

    . Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory. Mov Disord 1996; 1: 167–73
22. 22.↵
    1. Ciarmiello A,
    2. Cannella M,
    3. Lastoria S,
    4. et al

    . Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006; 47: 215–22

    Abstract/FREE Full Text
23. 23.↵
    1. Snook L,
    2. Plewes C,
    3. Beaulieu C

    . Voxel-based versus region of interest analysis in diffusion tensor imaging of neurodevelopment. Neuroimage 2007; 34: 243–52

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Seppi K,
    2. Scherfler C,
    3. Nocker M,
    4. et al

    . Diffusion weighted imaging in presymptomatic and early Huntington's disease. Mov Dis 2008; 23: 77
25. 25.↵
    1. Gomez-Tortosa E,
    2. MacDonald ME,
    3. Friend JC,
    4. et al

    . Quantitative neuropathological changes in presymptomatic Huntington's Disease. Ann Neurol 2001; 49: 29–34

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Myers RH,
    2. Vonsattel JP,
    3. Paskevich PS,
    4. et al

    . Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991; 50: 729–42

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Beaulieu C

    . The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 2002; 15: 435–55

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Minati L,
    2. Aquino D,
    3. Rampoldi S,
    4. et al

    . Biexponential and diffusional kurtosis imaging, and generalised diffusion-tensor imaging (GDTI) with rank-4 tensors: a study in a group of healthy subjects. MAGMA 2007; 20: 241–53

    CrossRefPubMed
29. 29.↵
    1. Sener RN

    . Echo-planar and gradient-echo diffusion MRI of normal brain iron in the globus pallidus. Clin Imaging 2002; 6: 371–74